
Bioorganic and Medicinal Chemistry p. 1863 - 1872 (2014)
Update date:2022-07-30
Topics: Molecular Hybridization
Chen, Wenmin
Zhan, Peng
Rai, Diwakar
De Clercq, Erik
Pannecouque, Christophe
Balzarini, Jan
Zhou, Zhongxia
Liu, Huiqing
Liu, Xinyong
Based on crystallographic overlays of the known inhibitors TMC125 and R221239 complexed in RT, we designed a novel series of 4-phenoxy-6-(phenylamino) pyridin-2(1H)-one derivatives as HIV NNRTIs by molecular hybridization approach. The biological testing results indicated that 2-pyridone scaffold of these inhibitors was indispensable for their anti-HIV-1 activity, and substitution of halogen at the 3-position of the 2-pyridone ring would decrease the anti-HIV activity. Four most potent compounds had anti-HIV-1 IIIB activities at low micromolar concentrations (EC50 = 0.15-0.84 μM), comparable to that of nevirapine and delavidine. Some compounds were selected to test their anti-HIV-1 RT inhibitory action and to perform molecular modeling studies to predict the binding mode of these 2-pyridone derivatives.
View Morewebsite:http://www.amadischem.com
Contact:86-571-89925085
Address:Watts Cosine.No.166.Xiangmao Road.
Chengdu NoVi Biotechnology Co., Ltd.(expird)
Contact:13551243286/028-81458053
Address:NO.168-1-224 JULONG ROAD WUHOU DISTRICT, CHENGDU CITY,SICHUAN PROVINCE
Contact:0550-7041128 0550-7090578
Address:Wangdian Street,Xinjie Town
website:http://www.maisonchem.com.cn
Contact:0086-311-83833777
Address:Leitou industrial district, xinji, shijiazhuang city, hebei province,
website:http://www.antaibio.com
Contact:0086-21-65663057
Address:Room 2108, Building 2,No. 489 Zhengli Road,200433
Doi:10.1016/j.saa.2013.12.102
(2014)Doi:10.1055/s-0034-1380384
(2015)Doi:10.1080/10426500490475166
(2004)Doi:10.1021/jm00036a016
(1994)Doi:10.1021/jm00014a008
(1995)Doi:10.1016/S0040-4020(01)85382-5
(1994)